-
-
The future of pharmacy practice has become a focus for one pharmacy group, and the reaction from members has been favorable and enthusiastic.
-
The U.S. Food and Drug Administration (FDA) has announced a new initiative to fight drug counterfeiters. As part of the initiative, an internal task force will look into technology and other measures including better education of pharmacists to try to stop counterfeit drugs from being distributed with or deliberately substituted for safe and effective drugs.
-
These drugs recently received final approval from the U.S. Food and Drug Administration (FDA):
-
Pharmacist shortage continues despite lower vacancies; Scholarship campaign launched to recruit pharmacy teachers; Warnings added to topiramate and somatropin; ASHP speaks out againstmarket access bill
-
-
The recognition of non-accidental injury is critical for a pediatric
trauma patient. In the year 2000, almost 3 million reports of child
abuse were made to social service agencies. Forty-four percent of the
fatalities were children younger than 1 year of age. Not only are these
statistics alarming, but they point out the need for emergency
department and trauma physicians and nurses to recognize non-accidental
injury and aggressively protect the children who seek our medical
expertise and protection.
-
-
The skyrocketing cost of medical malpractice insurance has affected physicians throughout the nation. Many emergency physicians (EPs) have seen the costs of insurance nearly double in the past three years. Some insurers have deemed EPs with three claims against them in a five-year period as uninsurable. This months ED Legal Letter will provide insight into the malpractice crisis by looking at the cause, effect, and potential solutions to the problem. Furthermore, it will review why past legislative attempts to remedy previous malpractice crises have failed.
-
Recruiting students for research at universities and colleges is no longer as simple as having professors offer extra credit in exchange for participation. It has become an area that has created controversy within institutions and IRBs.
